The lyophilized drugs market has been gaining significant traction over the past few years owing to the widespread advantages associated with freeze-drying technique. Lyophilized drugs or freeze-dried drugs have better stability, longer shelf life and ease of transport as compared to conventional liquid formulations, as the process removes water content and allows preservation of drugs at ambient temperatures.
Lyophilized Drugs Market Trends in stabilizing drugs that are unstable when dissolved in solutions, and thus the technique is increasingly being adopted for drugs peptides and vaccines.
The global lyophilized drugs market is estimated to be valued at US$ 340.11 Bn in 2024 and is expected to exhibit a CAGR of 8.9% over the forecast period between 2024 to 2031.
Key players operating in the lyophilized drugs market are BASF SE, Evonik Industries AG, Clariant AG, DuPont de Nemours, Inc., Albemarle Corporation, Arkema SA, Johnson Matthey PLC, Mitsubishi Chemical Corporation, Honeywell International Inc., Shell Catalysts Technologies, W. R. Grace Co., Haldor Topsoe A/S, Dow Chemical Company, CRI Catalyst Company, and Sud-Chemie India Pvt. Ltd. (Clariant India Ltd.). The key players are engaged in expanding their production capacities and strategic collaborations with biopharmaceutical companies to cater to the growing demand for lyophilized drugs.
Get More Insights On, Lyophilized Drugs Market
Explore More Related Topic On, Sterile Injectables Market
For More Insights Discover the Report In language that Resonates with you
